Clincosm LogoSign in Get a demo

Advanced Cancer

Showing NaN - NaN of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease Trial in Puerto Rico, United States (MRTX849, Pembrolizumab,

Recruiting
  • Advanced Cancer
  • +2 more
  • Birmingham, Alabama
  • +97 more
Jan 6, 2023

Non Small Cell Lung Cancer, KRAS Activating Mutation, Advanced Cancer Trial in United States (VS-6766 and adagrasib)

Recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • avutometinib (VS-6766) and adagrasib
  • San Francisco, California
  • +4 more
Dec 21, 2022

Solid Tumor, Metastatic Cancer, Advanced Cancer Trial in United States (TJ210001)

Completed
  • Solid Tumor
  • +2 more
  • Aurora, Colorado
  • +3 more
Dec 9, 2022

Advanced Cancer Trial in Worldwide (Relatlimab, Nivolumab, BMS-986205)

Recruiting
  • Advanced Cancer
  • Relatlimab
  • +3 more
  • Duarte, California
  • +23 more
Oct 24, 2022

Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases Trial in United States (Botensilimab, Balstilimab)

Recruiting
  • Advanced Cancer
  • +7 more
  • Scottsdale, Arizona
  • +14 more
Sep 15, 2022

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in China, United States (TJ033721)

Recruiting
  • Solid Tumor
  • +6 more
  • Orange, California
  • +17 more
Aug 9, 2022

Advanced Cancer Trial in Aurora, New York (Psilocybin 25 mgs, Psilocybin 1 mg, Psychotherapy)

Not yet recruiting
  • Advanced Cancer
  • Psilocybin 25 mgs
  • +2 more
  • Aurora, Colorado
  • +1 more
May 26, 2022

Advanced Cancer Trial in Worldwide (Ipilimumab, BMS-986218, Nivolumab)

Recruiting
  • Advanced Cancer
  • Ipilimumab
  • +2 more
  • Aurora, Colorado
  • +55 more
Mar 7, 2022

Advanced Cancer Trial in Worldwide (BMS-986258, Nivolumab, rHuPH20)

Active, not recruiting
  • Advanced Cancer
  • BMS-986258
  • +2 more
  • Los Angeles, California
  • +15 more
Feb 11, 2022

Advanced Cancer Trial in Worldwide (BMS-986178, Nivolumab, Ipilimumab)

Completed
Has Results
  • Advanced Cancer
  • Aurora, Colorado
  • +21 more
Dec 25, 2021

Advanced Cancer Trial in Aurora (Counseling)

Active, not recruiting
  • Advanced Cancer
  • Counseling
  • Aurora, Colorado
    University of Colorado
Aug 18, 2021

Advanced Cancer Trial in Worldwide (Nivolumab, Daratumumab)

Completed
Has Results
  • Advanced Cancer
  • Nivolumab
  • Daratumumab
  • Long Beach, California
  • +19 more
Jul 2, 2021

Advanced Cancer Trial in Worldwide (Nivolumab, Dasatinib, Relatlimab)

Terminated
Has Results
  • Advanced Cancer
  • Nivolumab
  • +4 more
  • Duarte, California
  • +49 more
Feb 23, 2021

Advanced Cancer Trial in Aurora, Rochester, Philadelphia (ARRY-142886, MEK inhibitor; oral)

Completed
  • Advanced Cancer
  • ARRY-142886, MEK inhibitor; oral
  • Aurora, Colorado
  • +2 more
Oct 12, 2020

Advanced Cancer Trial in Canada, United States (ARRY-334543, EGFR/ErbB2 inhibitor; oral, Capecitabine, 5-fluorouracil prodrug;

Completed
  • Advanced Cancer
  • ARRY-334543, EGFR/ErbB2 inhibitor; oral
  • Capecitabine, 5-fluorouracil prodrug; oral
  • Aurora, Colorado
  • +3 more
Oct 2, 2020

Advanced Cancer Trial in Aurora, Rochester, Nashville (ARRY-334543, EGFR/ErbB2 inhibitor; oral, Docetaxel, mitotic inhibitor;

Completed
  • Advanced Cancer
  • ARRY-334543, EGFR/ErbB2 inhibitor; oral
  • +2 more
  • Aurora, Colorado
  • +2 more
Oct 2, 2020

Advanced Cancer Trial in United States (Taladegib)

Completed
Has Results
  • Advanced Cancer
  • Scottsdale, Arizona
  • +11 more
Aug 7, 2019

Advanced Cancer Trial in Worldwide (PF-05212384, PD-0325901, irinotecan)

Terminated
Has Results
  • Advanced Cancer
  • Los Angeles, California
  • +17 more
Feb 13, 2018

Advanced Cancer Trial in United States (crizotinib)

Completed
Has Results
  • Advanced Cancer
  • Los Angeles, California
  • +19 more
Jan 5, 2018

Advanced Cancer Trial in Aurora, Boston (ENMD-2076)

Completed
  • Advanced Cancer
  • Aurora, Colorado
  • +1 more
Jan 26, 2016

Advanced Cancer Trial in Scottsdale, Aurora, Buffalo (RDEA119)

Completed
  • Advanced Cancer
  • Scottsdale, Arizona
  • +2 more
Dec 30, 2014

Advanced Cancer, Pancreatic Cancer Trial in United States (ARRY-334543, EGFR/ErbB2 inhibitor; oral, Gemcitabine, nucleoside

Completed
  • Advanced Cancer
  • Pancreatic Cancer
  • ARRY-334543, EGFR/ErbB2 inhibitor; oral
  • Gemcitabine, nucleoside analogue; intravenous
  • Phoenix, Arizona
  • +5 more
Sep 28, 2012